Are cytoskeletal components involved in the control of hepatic carnitine palmitoyltransferase I activity?

Biochem Biophys Res Commun. 1996 Jul 25;224(3):754-9. doi: 10.1006/bbrc.1996.1095.

Abstract

The present work was undertaken to test whether cytoskeletal components are involved in the control of rat-liver carnitine palmitoyltransferase I (CPT-I) activity by cellular effectors. The microtubule stabilizer taxol abolished the changes in CPT-I activity induced by the effectors tested. Taxol also prevented OA-induced shrinkage of hepatocytes as well as the enhanced release of lactate dehydrogenase from digitonin-permeabilized hepatocytes. On the basis of its relative sensitivity to tautomycin and OA, the modulation of CPT-I activity seemed to involve mostly protein phosphatase 1. These data suggest that the short-term control of hepatic CPT-I by cellular effectors may involve modulation of interactions between CPT-I and cytoskeletal components.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antifungal Agents / pharmacology
  • Bucladesine / pharmacology
  • Carnitine O-Palmitoyltransferase / metabolism*
  • Cells, Cultured
  • Cytoskeleton / drug effects
  • Cytoskeleton / metabolism*
  • Enzyme Inhibitors / pharmacology
  • Ethers, Cyclic / pharmacology
  • Glutamine / pharmacology
  • Liver / cytology
  • Liver / enzymology*
  • Male
  • Microtubules / drug effects
  • Okadaic Acid
  • Paclitaxel / pharmacology
  • Phosphoprotein Phosphatases / antagonists & inhibitors
  • Protein Phosphatase 1
  • Pyrans*
  • Rats
  • Rats, Wistar
  • Spiro Compounds*
  • Vanadates / pharmacology

Substances

  • Antifungal Agents
  • Enzyme Inhibitors
  • Ethers, Cyclic
  • Pyrans
  • Spiro Compounds
  • Glutamine
  • tautomycin
  • Okadaic Acid
  • Vanadates
  • Bucladesine
  • Carnitine O-Palmitoyltransferase
  • Phosphoprotein Phosphatases
  • Protein Phosphatase 1
  • Paclitaxel